Purpose and Summary
H.R. 7218 reauthorizes programs to support states, local
public health departments, and other entities that educate and
support early detection and diagnosis, support patients and
caregivers needs, and promote public health knowledge and
awareness of Alzheimer's disease and related dementias, among
other activities, for fiscal years 2025 through 2029.
Background and Need for Legislation
The ``BOLD (Building Our Largest Dementia) Infrastructure
for Alzheimer's Act'' utilizes population-level approaches to
prevent Alzheimer's and related dementias and improve outcomes
by promoting cognitive health. The law provides funding to
support public health strategies that promote brain health,
address dementia, and support individuals living with
Alzheimer's and related dementia and their caregivers. An
estimated 6.7 million Americans aged 65 and older are living
with Alzheimer's in 2023. By 2050, this number is projected to
rise to 12.7 million. About 1 in 9 people aged 65 and older
(10.7 percent) have Alzheimer's, and 1 in 3 seniors dies with
Alzheimer's or another dementia.\1\
---------------------------------------------------------------------------
\1\Alzheimer's Association, ``Alzheimer's Disease Facts and
Figures'', 2024. https://www.alz.org/alzheimers-dementia/facts-figures.
---------------------------------------------------------------------------
Committee Action
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7218. The title of the hearing was
``Legislative Proposals to Support Patients and Caregivers.''
The Subcommittee received testimony from:
Andy Shih, PhD, Chief Science Officer,
Autism Speaks;
Corey Feist, JD, MBA, Co-Founder and CEO,
Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and CEO,
Alzheimer's Association;
Gordon Tomaselli, MD, Former President,
American Heart Association; Marilyn and Stanley M. Katz
Dean, Emeritus and Professor of Medicine, Albert
Einstein College of Medicine; Adjunct Professor of
Medicine, Johns Hopkins University School of Medicine;
Michelle Whitten, President, CEO, and Co-
Founder, Global Down Syndrome Foundation;
Randy Strozyk, President, American Ambulance
Association; and
Christina Annunziata, MD, PhD, Senior Vice
President of Extramural Discovery Science, American
Cancer Society.
On March 12, 2024, the Subcommittee on Health met in open
markup session and forwarded H.R. 7218, without amendment, to
the full Committee by a record vote of 25 yeas and 0 nays.
On March 20, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 7218,
without amendment, favorably reported to the House by a record
vote of 44 yeas and 0 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held a hearing and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority, and Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 7218 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to promote
public health knowledge and awareness of Alzheimer's disease
and related dementias.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 7218 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearing was used to develop or consider H.R. 7218:
On February 14, 2024, the Subcommittee on
Health held a hearing on H.R. 7218. The title of the
hearing was ``Legislative Proposals to Support Patients
and Caregivers.'' The Subcommittee received testimony
from:
Andy Shih, PhD, Chief Science
Officer, Autism Speaks;
Corey Feist, JD, MBA, Co-Founder
and CEO, Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and
CEO, Alzheimer's Association;
Gordon Tomaselli, MD, Former
President, American Heart Association; Marilyn
and Stanley M. Katz Dean, Emeritus and
Professor of Medicine, Albert Einstein College
of Medicine; Adjunct Professor of Medicine,
Johns Hopkins University School of Medicine;
Michelle Whitten, President,
CEO, and Co-Founder, Global Down Syndrome
Foundation; o Randy Strozyk, President,
American Ambulance Association; and
Christina Annunziata, MD, PhD,
Senior Vice President of Extramural Discovery
Science, American Cancer Society.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 7218 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides that the Act may be cited as the ``BOLD
Infrastructure for Alzheimer's Reauthorization Act of 2024.''
Section 2. Extension of program for promotion of public health
knowledge and awareness of Alzheimer's disease and related
dementias
Section 2 reauthorizes the ``BOLD Infrastructure Act'' for
five years from fiscal year 2025 through fiscal year 2029.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (new matter is
printed in italics and existing law in which no change is
proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE III--GENERAL POWERS AND DUTIES OF PUBLIC HEALTH SERVICE
* * * * * * *
Part K--Health Care Services in the Home and Public Health Programs for
Dementia
* * * * * * *
Subpart II--Programs With Respect to Alzheimer's Disease and Related
Dementias
* * * * * * *
SEC. 398B. GENERAL PROVISIONS.
(a) Limitation on Administrative Expenses.--The Secretary may
not make a grant or cooperative agreement under sections 398 or
398A to an entity unless the entity agrees that not more than 5
percent of the grant or cooperative agreement will be expended
for administrative expenses with respect to the grant or
cooperative agreement.
(b) Requirement of Application.--The Secretary may not make a
grant under sections 398 or 398A to an entity unless the entity
has submitted to the Secretary an application for the grant.
The application shall--
(1) contain the description of intended expenditures;
(2) with respect to carrying out the purpose for
which the grant is to be made, provide assurances of
compliance satisfactory to the Secretary; and
(3) otherwise be in such form, be made in such
manner, and contain such information and agreements as
the Secretary determines to be necessary to carry out
this subpart.
(c) Evaluations and Report by Secretary.--The Secretary
shall--
(1) provide for an evaluation of the activities for
which an award is made under sections 398 or 398A; and
(2) not later than 1 year after the completion of
such evaluations, submit to the Congress a report
describing the findings made as a result of the
evaluations.
(d) Definition.--In this subpart, the terms ``Indian tribe''
and ``tribal organization'' have the meanings given such terms
in section 4 of the Indian Health Care Improvement Act.
(e) Authorizations of Appropriations.--For the purpose of
carrying out this subpart, there are authorized to be
appropriated $20,000,000 for each of fiscal years 2020 through
2024 and $33,000,000 for each of fiscal years 2025 through
2029.
* * * * * * *
[all]